TABLE 1.
SecA fragment (kDa) | N-terminal sequence |
---|---|
Generated in the presence of membrane | |
Extracted from membrane | |
66 | 14NDRT |
48 | 361EGVQIQNENQ |
36 | 1MLIKLLtKVF |
9vFGSRNDRTL | |
14nDRTLRRMRK | |
31 | 361EGVQIQNENQ |
575SGRQGdaGS | |
s29 | 361EGVQIQNENQ |
Recovered from supernatant | |
66 | 9VFGSRNDRTL |
14NDRTLRRMRK | |
36 | 9VFGSRNDRTL |
14NDRTLRRMRK | |
s29 | 361EGVQIQNENQ |
Generated in the absence of membrane | |
In buffer containing ATP and precursor | |
66 | 9VFGSRNDRTL |
14NDRTLRRMRK | |
36 | 9VFGSRNDRTL |
14NDRTLRRMRK | |
s29 | 361EGVQIQNENQ |
In buffer with low trypsin | |
66 | 9VFGSRNDRTL |
50 | 9VFGsRNDRTL |
36 | 104TGEGKTLTAT |
30 | 644QLLEQQDVA |
SecA fragments were generated in the presence of membranes as described in Materials and Methods and were subjected to peptide-sequencing analysis. Soluble SecA (1 mg/ml) was digested with trypsin on ice for 15 min in buffer in the presence of energy source and proOmpA (1 mg of trypsin/ml) or in the absence of energy source and proOmpA (20 μg of trypsin/ml). The resulting SecA fragments were then analyzed in the same manner as the SecA fragments generated in the presence of membranes. Identified SecA sequences are shown in single-letter code. Uppercase letters represent amino acids of the analyzed sequences which match the known SecA sequence (31), whereas lowercase letters represent unconfirmed residues.